Home/Vasgen/Salman Rahman
SR

Salman Rahman

CEO & Co-founder

Vasgen

Therapeutic Areas

Vasgen Pipeline

DrugIndicationPhase
ADAM15 Inhibitor ProgramOcular Neovascular Disease (e.g., wet AMD) & Solid Tumors (e.g., Prostate/Breast Cancer)Pre-clinical